Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: a multicentre MITO retrospective study
Objectives. To evaluate the impact of tertiary cytoreductive surgery (TCS) on survival in recurrent epithelial
ovarian cancer (EOC), and to determine predictors of complete cytoreduction.
Methods. A multi-institutional retrospective study was conducted within theMITO Group on a 5-year observation
period.
Results. A total of 103 EOC patients with a ?6 month treatment-free interval (TFI) undergoing TCS were included.
Complete cytoreduction was achieved in 71 patients (68.9%), with severe post-operative complications